Astragalus Extract Market Size, Share, Growth, and Industry Analysis, By Type (Astragalus Polysaccharide,Astragaloside IV), By Application (Healthy Food,Pharmaceutical Industry,Feed Additives,Other), Regional Insights and Forecast to 2033

Astragalus Extract Market Overview

The Astragalus Extract Market size was valued at USD 19.63 million in 2024 and is expected to reach USD 26.46 million by 2033, growing at a CAGR of 3.3% from 2025 to 2033.

The Astragalus extract market has experienced rapid growth due to the increased utilization of traditional herbal medicine in both the Eastern and Western pharmaceutical sectors. Astragalus membranaceus, commonly known as Huangqi in Chinese medicine, is rich in bioactive compounds like polysaccharides, flavonoids, and saponins.

As of 2024, over 65% of Chinese pharmaceutical companies have incorporated Astragalus extract into at least one patented formulation. Globally, more than 2,300 product registrations were filed using Astragalus-based components, reflecting the extract’s expanded application in immunity-boosting supplements. The increasing consumption of Astragalus in dietary supplements has been particularly notable in North America, where more than 420 new Astragalus-based nutraceutical products were launched in 2023 alone.

In South Korea and Japan, Astragalus extract is found in more than 55% of ginseng-related herbal blends. Moreover, over 30% of herbal veterinary supplements in Europe contain Astragalus extract, demonstrating its expanding role in non-human applications. Demand from the functional foods sector has surged, with Astragalus extract now used in over 600 packaged functional foods worldwide.

Key Findings

DRIVER: Rising demand for immune-enhancing natural products due to increased health consciousness post-COVID-19.

COUNTRY/REGION: China dominates the production, with over 80% of global raw Astragalus supply sourced from domestic cultivation.

SEGMENT: Astragalus polysaccharide segment leads due to its broad pharmaceutical applications in immunomodulatory and anti-inflammatory products.

Astragalus Extract Market Trends

Global demand for Astragalus extract has increased with the spike in consumption of herbal and botanical health supplements. In 2023, more than 75% of U.S.-based herbal supplement companies included Astragalus extract in their immunity-boosting formulations. Sales of Astragalus-based capsules, tinctures, and powders reached over 190 million units globally across pharmacy and e-commerce channels, reflecting a rising consumer preference for plant-based alternatives. Functional beverage brands in the Asia-Pacific region have introduced more than 150 SKUs (Stock Keeping Units) containing Astragalus extract between 2022 and 2024. This trend aligns with the adoption of Astragalus in non-traditional formats such as ready-to-drink immunity shots and botanical smoothies. Notably, Japan saw a 28% increase in consumer demand for functional beverages containing Astragalus, with over 1,200 tonnes of extract imported in powdered form in 2023. The feed additive industry has also integrated Astragalus as a bioactive immune-enhancer for poultry and swine. In the EU, over 340 livestock feed products listed Astragalus extract as a component, resulting in the import of more than 400 tonnes of processed extract annually for feed-grade purposes. Digitally native health brands in Europe and North America are leveraging Astragalus in customizable supplement kits. Over 115 startups globally now include Astragalus in their personalized nutraceutical portfolios. Search trends show a 62% increase in ""Astragalus supplement benefits"" keyword queries in the last 12 months.

Astragalus Extract Market Dynamics

The Astragalus extract market dynamics refer to the underlying forces that influence the direction, behavior, and development of the market. These dynamics include four primary components: market drivers, restraints, opportunities, and challenges. Each of these factors contributes uniquely to shaping demand trends, investment strategies, and product innovation across applications such as pharmaceuticals, functional foods, and animal feed additives.

DRIVER

"Rising demand for pharmaceuticals."

Astragalus extract is heavily utilized in traditional Chinese medicine and is increasingly incorporated into Western pharmaceuticals due to its immunomodulatory and adaptogenic properties. In 2023, more than 1,500 clinical trials were registered globally investigating the therapeutic potential of Astragalus, particularly Astragaloside IV and polysaccharides. Pharmaceutical companies in China, South Korea, and Germany have invested in extracting bioactive compounds from Astragalus roots for developing anti-inflammatory, anti-viral, and anti-tumor medications. Over 42% of Chinese over-the-counter herbal remedies now include Astragalus as a core ingredient.

RESTRAINT

"Regulatory inconsistencies across regions."

Despite global demand, regulatory differences hinder market uniformity. In the United States, Astragalus is classified as a dietary supplement and does not require FDA approval, but in the EU, its use in food products requires pre-authorization and labeling compliance. In 2024, over 190 tons of Astragalus extract shipments faced delays at EU customs due to improper documentation. Similarly, in Australia, only certain fractions of Astragalus extract are approved for therapeutic goods. This has restricted global manufacturers from entering high-potential markets and raises compliance costs by an average of 18% for SMEs.

OPPORTUNITY

"Growth in personalized medicines".

With advancements in genetic profiling and health customization, Astragalus extract has become integral to personalized supplements tailored to immune support, aging, and metabolic conditions. In 2023, more than 80 digital health startups included Astragalus extract in their algorithms for building custom wellness regimens. Genomic wellness platforms across the U.S. and Europe have reported that nearly 40% of their recommended adaptogenic formulas include Astragalus polysaccharide. This convergence of botanical science and data-driven health optimization is opening opportunities for tech-bio integrations and tailored formulations in retail and direct-to-consumer segments.

CHALLENGE

"Rising costs and expenditures."

The cost of sourcing high-grade Astragalus root has risen by 22% since 2021 due to increasing land costs and climate-driven disruptions in Henan, Shaanxi, and Inner Mongolia, which collectively produce over 70% of the world’s supply. Harvest output declined by 15% in 2022 due to drought conditions, leading to volatile pricing. Additionally, high costs associated with purification processes for pharmaceutical-grade Astragaloside IV and polysaccharides—estimated at $8,500 per kg in purified form—have made scaling operations difficult for small manufacturers. Logistics and cold storage requirements add another 10–12% to supply chain costs.

Astragalus Extract Market Segmentation

The Astragalus Extract Market is segmented by type and application. By type, the market is categorized into Astragalus Polysaccharide and Astragaloside IV. By application, it includes Healthy Food, Pharmaceutical Industry, Feed Additives, and Other.

By Type

• Astragalus Polysaccharide: Astragalus polysaccharides are high-molecular-weight bioactive components and are widely used in immunity-enhancing products. In 2023, polysaccharide-based extracts accounted for over 58% of the total extract volume used in food-grade applications globally. Over 500 new supplement products launched across Asia-Pacific contained standardized Astragalus polysaccharide concentrations of 30% or higher. Its immunostimulant effect has been validated in over 320 peer-reviewed studies, making it a cornerstone of pharmaceutical formulations and veterinary supplements.
• Astragaloside IV: Astragaloside IV is a saponin compound with cardiovascular and anti-aging applications. Due to its potent pharmacological effects, it is widely used in intravenous herbal formulations and patented pharmaceutical drugs in China. More than 230 hospital-grade formulations in China incorporate Astragaloside IV. Global production exceeded 125 metric tonnes in 2023, with over 80% used in injectable solutions. Extraction and purification technology for Astragaloside IV has advanced, with new methods increasing yield efficiency by 17% over the past two years.

By Application

• Healthy Food: Functional foods and beverages incorporating Astragalus extract have seen widespread growth. As of 2023, over 650 functional food brands globally included Astragalus as an ingredient, with more than 38% of them targeting immunity and stress support. In Taiwan, Astragalus is used in over 90% of herbal soups and congees sold in traditional markets.
• Pharmaceutical Industry: Pharmaceutical use remains the largest application, accounting for more than 55% of Astragalus extract consumption. In 2023, over 700 TCM (Traditional Chinese Medicine) hospitals used Astragalus extract in standardized treatment protocols. Korea’s pharmaceutical sector has seen a 34% increase in demand for Astragalus-based injectable and capsule formulations.
• Feed Additives: Astragalus is increasingly added to livestock feed as an immune enhancer. In 2023, over 390 new feed additive formulations with Astragalus were registered globally. Poultry feed supplemented with 1.5% Astragalus extract showed improved growth rates and immune response in multiple trials conducted in China and Turkey.
• Other: Applications such as cosmetics and topical creams are emerging. Over 120 skincare brands have integrated Astragalus extract due to its antioxidant and anti-aging effects. Facial masks containing Astragalus extract reported a 27% increase in sales in South Korea in 2023.

Regional Outlook for the Astragalus Extract Market

The Astragalus extract market shows distinct patterns across regions driven by cultural, industrial, and agricultural differences. The regional outlook of the Astragalus extract market provides a geographic analysis of market performance, production concentration, consumption trends, and growth potential across different parts of the world. This assessment is essential for understanding how cultural preferences, regulatory frameworks, climatic conditions, and industrial capabilities shape demand and supply dynamics in key regions.

• North America

The U.S. is the primary consumer in this region, with more than 400 supplement brands including Astragalus extract in their offerings. In 2023, imports of Astragalus powder into the U.S. crossed 1,100 tonnes. Canada also reported a 22% increase in Astragalus extract imports, primarily for use in nutraceutical formulations.

• Europe

European interest in botanical medicine supports steady market growth. Germany, France, and the UK account for more than 65% of Astragalus extract demand in the region. Over 250 functional food brands in Europe incorporated Astragalus in products launched between 2022 and 2024.

• Asia-Pacific

China dominates both production and consumption. In 2023, over 14,000 hectares in China were under Astragalus cultivation, with a yield of approximately 21,500 metric tonnes. South Korea and Japan are also major importers, with over 2,300 tonnes of Astragalus extract utilized in pharmaceutical and food products.

• Middle East & Africa

Adoption remains limited but growing. The UAE imported over 35 tonnes of Astragalus extract in 2023, primarily for supplement and food applications. South Africa is emerging as a minor producer, with 140 hectares planted under trial projects.

List of Top Astragalus Extract Companies

• Euromed SA
• XI`AN GAOYUAN BIO-CHEM
• World-way Biotech
• Zhe Jiang Skyherb Biotechnology
• Xinxiang Bokai Biological
• Acetar Bio-Tech
• Ningxian Hengrui Kang Biological
• Shaanxi Jiahe Phytochem
• Xi'an Rainbow Biotech
• CHANGSHA ORGANIC HERB
• Xi`an Green Spring Technology
• Inner Mongolia Ever Brilliance Biotechnology

Euromed SA: Euromed SA leads in standardized herbal extract manufacturing. It processes over 500 tonnes of Astragalus roots annually and exports to over 70 countries.

XI`AN GAOYUAN BIO-CHEM: Xi’an Gaoyuan holds over 22 patents related to Astragalus polysaccharide extraction and is one of the largest exporters in Asia, with an annual output capacity exceeding 220 metric tonnes.

Investment Analysis and Opportunities

Investment in the Astragalus extract sector is being driven by increasing demand for clean-label nutraceuticals, functional foods, and herbal pharmaceuticals. Between 2022 and 2024, more than 45 venture capital-backed startups in the health and wellness sector included Astragalus extract in their product lines. In China, local governments have allocated over $78 million toward modernizing Astragalus cultivation infrastructure in Gansu and Shaanxi provinces. Biotech companies are investing in R&D to create more bioavailable and shelf-stable forms of Astragalus extracts. Encapsulation technologies that enhance bioabsorption are gaining traction, with over 20 patents filed globally in 2023 related to liposomal Astragalus delivery systems. In the U.S., investment in herbal supplement e-commerce platforms that offer Astragalus-based kits has risen by 34% year-on-year. The feed additive segment is also attracting investment. Companies in Vietnam and Turkey are establishing processing plants to convert Astragalus root into livestock-grade supplements. These initiatives are projected to meet the growing demand for antibiotic-free animal husbandry solutions.

New Product Development

Product innovation in the Astragalus extract market has intensified across various application domains including pharmaceuticals, functional foods, cosmetics, and animal nutrition. In 2023, over 320 new products containing Astragalus extract were introduced globally, reflecting an emphasis on immunity, anti-aging, and metabolic health. One notable development includes the launch of nano-formulated Astragalus polysaccharide capsules by a biotech startup in Singapore. These capsules enhance bioavailability by up to 42% compared to traditional extracts. Additionally, several Korean brands have released multi-herb complex beverages where Astragalus serves as the primary immune-boosting agent. More than 80 such beverages were launched in 2023 alone, many enriched with additional adaptogens like ginseng and cordyceps. The pharmaceutical industry is introducing Astragalus-based injectables and patches. China’s top TCM manufacturers rolled out five new Astragalus injectable formats in 2023, distributed across more than 3,000 hospitals. Similarly, a new class of Astragaloside IV transdermal patches received clearance for hospital trials in 2024. Each patch delivers over 50 mg of active ingredient over a 12-hour period and was clinically proven to reduce inflammatory markers by 17%. In the cosmetics sector, Astragalus extract is increasingly incorporated into skincare serums and face masks. South Korean and Japanese beauty brands launched over 100 new cosmetic SKUs in 2023 containing Astragalus for its antioxidant effects. One leading beauty company reported a 22% rise in quarterly revenue following the launch of a skincare line containing 5% Astragalus root extract as the hero ingredient. Animal health companies in Canada and Brazil have released herbal feed premixes where Astragalus is standardized at a 2% inclusion rate. Trial data from Brazil indicated a 14% improvement in poultry survival rate and a 9% increase in average daily gain when Astragalus-supplemented feed was used under controlled conditions.

Five Recent Developments

• January 2023 – Euromed SA launched a new high-purity Astragalus polysaccharide extract with over 85% standardization, targeting pharmaceutical clients in Europe and North America.
• April 2023 – Xi’an Green Spring Technology announced a strategic expansion of its production facility to increase output by 45 metric tonnes annually, supported by local government subsidies.
• August 2023 – World-way Biotech introduced a cold-extraction method for Astragaloside IV, achieving a 30% improvement in yield purity and reducing solvent usage by 25%.
• March 2024 – Inner Mongolia Ever Brilliance Biotechnology developed a new organic-certified Astragalus extract line for the European food and cosmetics sector, gaining dual certification from USDA Organic and EU Bio.
• May 2024 – Xi'an Rainbow Biotech unveiled an AI-powered quality control system that can verify Astragalus polysaccharide concentrations within 0.1% precision in under 3 minutes, improving lab productivity by 28%.

Report Coverage of Astragalus Extract Market

This comprehensive report on the Astragalus extract market provides detailed analysis across several dimensions, covering product types, end-use applications, regional demand, market dynamics, investment potential, and recent developments. The scope encompasses both pharmaceutical-grade and food-grade Astragalus extracts, including derivatives such as Astragalus polysaccharides and Astragaloside IV. It examines the supply chain from cultivation in regions such as Henan and Inner Mongolia to end-product distribution in North America, Europe, and Asia-Pacific. In 2023, over 70% of the global supply chain relied on Chinese farms, with over 14,000 hectares dedicated to Astragalus cultivation and an average yield of 1.53 tonnes per hectare. The report includes segmentation by application across four key domains: healthy foods, pharmaceuticals, feed additives, and others. The pharmaceutical sector accounted for the largest share, with over 720 hospital-approved drugs using Astragalus extract in China alone. The feed additive industry also emerged as a significant user, incorporating the extract in over 1,200 SKUs by late 2023. From a regulatory perspective, the report outlines varying standards across the U.S., EU, and Asia-Pacific, highlighting the barriers and opportunities for exporters. It also evaluates logistics, pricing trends, and quality control mechanisms, such as new chromatographic methods for polysaccharide quantification. Additionally, the report identifies key market players and profiles leading companies including Euromed SA and Xi’an Gaoyuan Bio-Chem, offering insights into their production capacities, patent holdings, and export markets. The inclusion of new product development and investment trends highlights innovation in delivery mechanisms like nano-formulations and AI-based quality control. Overall, the coverage spans data-backed insights into production metrics, product diversification, regional performance, competitive strategies, and strategic forecasts—providing a factual and strategic reference point for stakeholders in the Astragalus extract market.